{
    "startDate": "2019-08-01",
    "endDate": "2020-07-31",
    "year": "2020",
    "quarter": "FY",
    "symbol": "RFL",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents, beginning of year",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 6206000
            },
            {
                "label": "Trade accounts receivable, net of allowance for doubtful accounts of $218 and $122 at July 31, 2020 and 2019, respectively",
                "concept": "ReceivablesNetCurrent",
                "unit": "usd",
                "value": 267000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 273000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 9832000
            },
            {
                "label": "Total",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 44433000
            },
            {
                "label": "Investments \u2013 Rafael Pharmaceuticals",
                "concept": "LongTermInvestments",
                "unit": "usd",
                "value": 70018000
            },
            {
                "label": "Deferred income tax assets, net",
                "concept": "DeferredIncomeTaxAssetsNet",
                "unit": "usd",
                "value": 6000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 1580000
            },
            {
                "label": "Total current assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 136347000
            },
            {
                "label": "Trade accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 921000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1191000
            },
            {
                "label": "Amount due for purchase of membership interest",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 3500000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 5727000
            },
            {
                "label": "Convertible debt, net of discount of $0 and $54 - Related Party",
                "concept": "ConvertibleDebtNoncurrent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 92000
            },
            {
                "label": "Accrued interest on convertible debt - Related Party",
                "concept": "LongTermNotesPayable",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total current liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 5819000
            },
            {
                "label": "Commitments and Contingencies Disclosure [Abstract]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 129136000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -16255000
            },
            {
                "label": "Accumulated other comprehensive income related to foreign currency translation adjustment",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 3762000
            },
            {
                "label": "Total equity attributable to Rafael Holdings, Inc.",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 116800000
            },
            {
                "label": "Noncontrolling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 13728000
            },
            {
                "label": "TOTAL EQUITY",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 130528000
            },
            {
                "label": "TOTAL LIABILITIES AND EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 136347000
            }
        ],
        "cf": [
            {
                "label": "Consolidated net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -10753000
            },
            {
                "label": "Depreciation",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 1866000
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxesAndTaxCredits",
                "unit": "usd",
                "value": 13000
            },
            {
                "label": "Gain on sale of marketable securities",
                "concept": "MarketableSecuritiesGainLoss",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Impairment of investments - Other Pharmaceuticals",
                "concept": "ImpairmentOfInvestments",
                "unit": "usd",
                "value": 799000
            },
            {
                "label": "Equity in earnings of RP Finance",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 192000
            },
            {
                "label": "Provision for doubtful accounts",
                "concept": "ProvisionForDoubtfulAccounts",
                "unit": "usd",
                "value": 96000
            },
            {
                "label": "Noncash compensation",
                "concept": "EmployeeBenefitsAndShareBasedCompensationNoncash",
                "unit": "usd",
                "value": 684000
            },
            {
                "label": "Amortization of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 54000
            },
            {
                "label": "Trade accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -87000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -234000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 168000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 713000
            },
            {
                "label": "Other current liabilities",
                "concept": "IncreaseDecreaseInOtherCurrentLiabilities",
                "unit": "usd",
                "value": 88000
            },
            {
                "label": "Due to related parties",
                "concept": "IncreaseDecreaseInDueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": -65000
            },
            {
                "label": "Due from related parties",
                "concept": "IncreaseDecreaseInDueFromRelatedParties",
                "unit": "usd",
                "value": -162000
            },
            {
                "label": "Accrued interest - Related Party",
                "concept": "InterestExpenseRelatedParty",
                "unit": "usd",
                "value": 19000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -4666000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 534000
            },
            {
                "label": "Proceeds from sale and maturity of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Investment in Rafael Pharmaceuticals",
                "concept": "PaymentsToAcquireInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -1034000
            },
            {
                "label": "Contribution from noncontrolling interest of consolidated entity",
                "concept": "ProceedsFromMinorityShareholders",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Repayment of loan from Rafael Pharmaceuticals, including interest",
                "concept": "ProceedsFromRepaymentsOfRelatedPartyDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from exercise of options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 29000
            },
            {
                "label": "Proceed from sale of shares",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from issuance of convertible note",
                "concept": "ProceedsFromConvertibleDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash (used in) provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -96000
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": -22000
            },
            {
                "label": "Net decrease in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": -5818000
            }
        ],
        "ic": [
            {
                "label": "Rental \u2013 Third Party",
                "concept": "OperatingLeasesIncomeStatementLeaseRevenue",
                "unit": "usd",
                "value": 1516000
            },
            {
                "label": "Rental \u2013 Related Party",
                "concept": "RevenueFromRelatedParties",
                "unit": "usd",
                "value": 2082000
            },
            {
                "label": "Total Revenue",
                "concept": "Revenues",
                "unit": "usd",
                "value": 4910000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 9118000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 2391000
            },
            {
                "label": "Depreciation",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 1866000
            },
            {
                "label": "Interest (expense) income, net",
                "concept": "InterestIncomeExpenseNet",
                "unit": "usd",
                "value": -32000
            },
            {
                "label": "Net (loss) gain resulting from foreign exchange transactions",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": -5000
            },
            {
                "label": "Gain on sale of marketable securities",
                "concept": "MarketableSecuritiesGainLoss",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Impairment of investments - Other Pharmaceuticals",
                "concept": "ImpairmentOfInvestments",
                "unit": "usd",
                "value": 799000
            },
            {
                "label": "Loss before income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -6916000
            },
            {
                "label": "(Provision for) benefit from income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 29000
            },
            {
                "label": "Equity in earnings of RP Finance",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 192000
            },
            {
                "label": "Consolidated net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -10753000
            },
            {
                "label": "Net loss attributable to noncontrolling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -338000
            },
            {
                "label": "Net loss attributable to Rafael Holdings, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -10415000
            },
            {
                "label": "Foreign Currency Translation Adjustment",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -22000
            },
            {
                "label": "Total Comprehensive Loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -10775000
            },
            {
                "label": "Comprehensive (loss) income attributable to noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 9000
            },
            {
                "label": "Total Comprehensive Loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -10784000
            },
            {
                "label": "Loss per share",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.66
            },
            {
                "label": "Basic and Diluted (in Shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 15764829
            }
        ]
    }
}